3.82
+3372.73%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Accuray
From its filings with the US Securities and Exchange Commission
Accuray is based in Madison, Wisconsin and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker ARAY. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 30 June 2026, it reported revenue of $401.9m and a net loss of $49.2m. At that date it held total assets of $443.7m and shareholders' equity of $41.7m.
Accuray Incorporated is a radiation therapy company that develops, manufactures, sells and supports treatment delivery, planning, imaging and data management solutions designed to help clinical teams deliver precise radiation treatments across a broad range of clinical cases. Our portfolio includes the CyberKnife robotic platform and a differentiated helical portfolio that includes the Accuray Stellar, Radixact, Accuray Helix and Tomo C Systems, where available. We believe these solutions provide clinicians with advanced capabilities to support accuracy, flexibility, motion management, image guidance, adaptive workflows and personalized treatment delivery.
Radiation therapy systems with software-enabled motion management capabilities designed to support real-time adaptation of treatment delivery for targets that move during treatment.
Treatment planning software that enables clinicians to use the differentiated capabilities of Accuray systems to create high-quality treatment plans and support precise, efficient treatment delivery across a broad range of clinical cases.
Automated tools designed to help clinicians identify anatomical changes during a course of treatment, evaluate whether re-planning may be clinically beneficial and adapt radiation dose to support treatment plan objectives.
Quoted from its 10-K, filed 27 Aug 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 8 Feb 2007
- Employees
- 990
- Website
- accuray.com ↗
- Head office
- 1240 DEMING WAY, MADISON, WI, 53717
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Ms. Suzanne WinterPresident, Chief Executive Officer, since 2019$3.0m
- Mr. Ali PervaizChief Financial Officer, Senior Vice President$1.1m
- Mr. Leonel PeraltaChief Operations Officer, Senior Vice President
- Mr. Sandeep ChalkeSenior Vice President, Chief Commercial Officer$1.2m
- Mr. Michael MurphyPrincipal Accounting Officer, Vice President, Corporate Controller
- Mr. James HindmanIndependent Director$208,725
- Ms. Beverly HussIndependent Director$198,725
- Mr. Robert KillIndependent Director$186,225
- Ms. Anne Le GrandIndependent Director$227,393
- Mr. Steven MayerIndependent Director$66,105
- Ms. Mika NishimuraIndependent Director$188,725
- Dr. Byron ScottIndependent Director$191,225
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 44
- Environment
- 14
- Social
- 83
- Governance
- 36
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Accuray Inc possesses several strengths that contribute to its competitive advantage in the market:
Weaknesses
- Despite its strengths, Accuray Inc faces certain weaknesses that may hinder its growth and profitability:
Opportunities
- Accuray Inc can leverage several opportunities to further expand its business and market reach:
Threats
- Accuray Inc faces various external threats that may impact its business operations and profitability:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.